Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Rigetti Computing Inc (RGTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Rigetti Computing Inc — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.04 (market cap $1.74B), while Rigetti Computing Inc trades at $13.9 (market cap $4.72B). The key difference: Rigetti Computing Inc is far larger — about 2.7× Nuvation Bio Inc. Class A Common Stock's market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, Rigetti Computing Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Rigetti Computing Inc for 34 Days on average.
| NUVB | RGTI | |
|---|---|---|
Market Cap | $1.74B | $4.72B |
Volume | 9,289,619 | 17,136,381 |
Sector | Health | Technology |
52-Week High | $9.54 | $56.34 |
52-Week Low | $3.41 | $12.90 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $1.33B | $4.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RGTI trades at $13.89, down 4.8% in the last session, amid bearish technical signals but strong analyst support. The company shows minimal revenue of $7.09M (2025) with significant losses (-$216.21M net income), though recent quarters saw mixed earnings beats. Positive sentiment stems from quantum computing sector momentum and strategic partnerships, yet high valuation ratios (P/S 349.79) and negative cash flow pose challenges.
Outlook: Analyst consensus is bullish (85.7% buy ratings) with a $21.67 price target, suggesting 56% upside, but high execution risks and cash burn require caution. Investment opportunity hinges on commercial scaling of quantum technology, while risks include sustained losses and competitive pressure in the emerging quantum sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Rigetti Computing Inc
Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →
